COX-2 CRAd (University of Alabama)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCOX-2 CRAd (University of Alabama)

Drug Alias Nameconditionally replicative adenovirus (University of Alabama at Birmingham)CRAdCRAdcox-2Foncolytic adenovirus therapy (University of Alabama at Birmingham)

ClassificationBiologics > Oncolytic virus

Mechanisms of ActionImmunostimulants

TargetsUpdating

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Alabama At Birmingham

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Alabama At Birmingham

Active IndicationsN/A

Inactive IndicationsGastrointestinal Neoplasms

Other Information

ATC CodeN/A